While advancing gas prices send Exmar into a tropical rally, GBL embraces a French non-profit to get rid of the stock discount.
Fueled by strong banking and energy values, European stocks will experience a recovery day on Tuesday after a shaky start to the week. A confident growth forecast from the German semiconductor manufacturer Infineon provides additional confidence. The Bel20
can under the impulse of KBC strengthened by 0.53 percent to 4,138 points.
does not participate in the modest recovery. The beer giant is the subject of rumors about its German brands. According to Bloomberg, AB InBev wants to sell all its German beers to a buyer. It would be with the sale of Beck’s, Franziskaner Weissbier and co. 1 billion euros.
‘No proposed scenario due to the limited growth potential of some of these brands’, says analyst Wim Hoste. “But it’s not a sale for debt.” Net debt at 4.4 times gross operating profit is still high, but does not require further divestments, according to Hoste. He predicts that the debt ratio will gradually increase to 2.9 by 2023.
AB InBev is trading flat at EUR 48.6.
cannot halt his never-ending loss streak. The biotech company reports new Phase 3 trial data on the use of filgotinib in the treatment of ulcerative colitis, a chronic inflammation of the inner lining of the intestinal wall. Overall development of long-term treatment with the drug (after 58 weeks) still notice an improvement in their clinical picture.
Those results offer no solace to the troubled Galapagos. The price continues to crumble by 0.8 percent to 43.7 euros. The new loss follows a strong price target cut by Citi. The analyst values the price target firmly from 79.1 to 51 euros with a neutral advice.
The stock is trading below its cash position, but there are few triggers to eliminate that discount, the report finds. The lack of clarity about the succession of CEO Onno van de Stolpe and scientific director Piet Wigerinck are also grounds for caution, according to Citi.
is putting itself more on the map in private equity through its venture capital branch Sienna. Sienna begins negotiations with Malakoff Humanis about a partnership in the industry of retirement savings and employee savings plans. Malakoff is a non-profit organization that manages 7 billion euros with more than 400,000 corporate clients. It has a clear social objective and spends 160 euros per year to support vulnerable vulnerable groups. Sienna and Malakoff want to save money in France.
For the trivia fans among GBL investors: Malakoff owes its special name to a municipality as proof of Paris. It was named after a battle fought by the Russians against the French in the Crimean War at the end of the 19th century. Malakoff was the birthplace of French primitive painter Henri Rousseau.
With Malakoff, GBL is clearly committed to sustainability in the hope of eliminating its valid stock discount. The holding company around the Frère family quotes a discount of an estimated 33 percent on the calculation of the value of the portfolio. The venture capital arm makes up between at least 12 percent of that value. Sienna wants to grow into a European investment group. It took over in July investment manager L’Etoile Properties, which manages 7 billion in the real estate sector.
GBL is struggling to gain exposure with its stronger sustainable focus. The news about the non-profit Malakoff could therefore have a positive effect on the share price, predicts ING analyst Hans D’Haese.
GBL is struggling to gain exposure with its stronger sustainable focus. The holding became large (meanwhile significantly reduced) interests in the oil and heavy industry sector. The cement participation Holcim was recently discredited by terror. Also the recent decision to organize an investor day in a fashionable hotel in Paris in November did not reflect the best judgment to strengthen ties with the small (ESG) investor.
The news about the non-profit Malakoff could therefore have a positive effect on the share price, predicts ING analyst Hans D’Haese. GBL gains 1 percent to 95.2 euros.
In the broad market Exmar
the star in an increasingly impressive gas rally. The gas carrier gains 5 percent and reaches the milestone of 5 euros for the first time since the coronavirus outbreak. In four weeks, Exmar gained weight by more than 40 percent. Strong demand and skyrocketing gas prices increase the chances of early employment for Exmar’s unemployed floating natural gas platform Tango.
Daddy Yankee – Gasolina, these days the anthem of Exmar’s ‘full throttle’ rally.
has received European approval to also treat the condition CCC, a collapse of the soft palate, with its Genio system. It obtained a license from ‘notified body’ DEKRA. Such a notified body of inspection body must verify that products comply with European directives.
‘This increases our market by 30 percent’, responds CEO Olivier Tallman.
“Nyxo has a clear step ahead of opah,” says Laura Roba, analyst at Degroof Petercam. ‘Genio is the only neurostimulation system approved for the treatment of apnea in CCC patients.’ The analyst sees an approval of Genio in the US as the next catalyst for the price. She estimates a 60 percent chance that Nyxoah will be able to market its implantable stimulator-based sleep system by 2023.
Nyxoah gains 2.4 percent to 25.3 euros.